Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents

Pediatric Research

Volumn 52, Issue 5, 2002, Pages 737-744

  Patel, Aneeta ^a   Jhiang, Sissy ^a   Dogra, Shalini ^a   Terrell, Richard ^a   Powers, Patricia A ^a   Fenton, Cydney ^a   Dinauer, Catherine A ^a   Tuttle, R Michael ^a   Francis, Gary L ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; SODIUM IODIDE SYMPORTER;

ADOLESCENT; AGE; ARTICLE; AUTOIMMUNE DISEASE; BENIGN TUMOR; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK; SCORING SYSTEM; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID TUMOR; TUMOR CLASSIFICATION;

EID: 0036841056     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200211000-00021     Document Type: Article

References (40)

1. Mitchell AM, Manley SW, Morris JC, Powell KA, Bergert ER, Mortimer RH 2001 Sodium iodide symporter (nis) gene expression in human placenta, Placenta 22:256-258
2. Nakamoto Y, Saga T, Misaki T, Kobayashi H, Sato N, Ishimori T, Kosugi S, Sakahara H, Konishi J 2000 Establishment and characterization of a breast cancer cell line expressing Na+/I-symporters for radioiodide concentrator gene therapy. J Nucl Med 41:1898-1904
3. Ajjan RA, Kamaruddin NA, Crisp M, Watson PF, Ludgate M, Weetman AP 1998 Regulation and tissue distribution of the human sodium iodide symporter gene. Clin Endocrinol (Oxf) 49:517-523
4. Caillou B, Troalen F, Baudin E, Talbot M, Filetti S, Schlumberger M, Bidart JM 1998 Na+/I- symporter distribution in human thyroid tissues: An immunohistochemical study. J Clin Endocrinol Metab 83:4102-4106
5. Pasca di Magliano M, Di Lauro R, Zannini M 2000 Pax8 has a key role in thyroid cell differentiation. Proc Natl Acad Sci USA 97:13144-13149
6. Schmutzler C, Kohrle J 2000 Retinoic acid redifferentiation therapy for thyroid cancer. Thyroid 10:393-406
7. Tanaka K, Otsuki T, Sonoo H, Yamamoto Y, Udagawa K, Kunisue H, Arime I, Yamamoto S, Kurebayashi J, Shimozuma K 2000 Semi-quantitative comparison of the differentiation markers and sodium iodide symporter messenger ribonucleic acids in papillary thyroid carcinomas using RT-PCR. Eur J Endocrinol 142:340-346
8. Ros P, Rossi DL, Acebron A, Santisteban P 1999 Thyroid-specific gene expression in the multi-step process of thyroid carcinogenesis. Biochimie 81:389-396
9. Arturi F, Russo D, Schlumberger M, du Villard JA, Caillou B, Vigneri P, Wicker R, Chiefari E, Suarez HG, Filetti S 1998 Iodide symporter gene expression in human thyroid tumors. J Clin Endocrinol Metab 83:2493-2496
10. Ringel MD, Anderson J, Souza SL, Burch HB, Tambascia M, Shriver CD, Tuttle RM 2001 Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer. Mod Pathol 14:289-296
11. Riedel C, Levy O, Carrasco N 2001 Post-transcriptional regulation of the sodium/iodide symporter (NIS) by thyrotropin. J Biol Chem 276:21458-21463
12. Eng PH, Cardona GR, Previti MC, Chin WW, Braverman LE 2001 Regulation of the sodium iodide symporter by iodide in FRTL-5 cells. Eur J Endocrinol 144:139-144
13. Arturi F, Russo D, Giuffrida D, Schlumberger M 2000 Sodium-iodide symporter (NIS) gene expression in lymph-node metastases of papillary thyroid carcinomas. Eur J Endocrinol 143:623-627
14. Pomerance M, Abdullah HB, Kamerji S, Correze C, Blondeau JP 2000 Thyroid-stimulating hormone and cyclic AMP activate p38 mitogen-activated protein kinase cascade: Involvement of protein kinase A, rac1, and reactive oxygen species. J Biol Chem 275:40539-40546
15. Kogai T, Schultz JJ, Johnson LS, Huang M, Brent GA 2000 Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line. Proc Natl Acad Sci USA 97:8519-8524
16. Filetti S, Bidart JM, Arturi F, Caillou B, Russo D, Schlumberger M 1999 Sodium/iodide symporter: A key transport system in thyroid cancer cell metabolism. Eur J Endocrinol 141:443-457
17. Spitzweg C, Morris JC 2000 The immune response to the iodide transporter. Endocrinol Metab Clin North Am 29:389-398, viii
18. Spitzweg C, Joba W, Morris JC, Heufelder AE 1999 Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells. Thyroid 9:821-830
19. Ajjan RA, Watson PF, Findlay C, Metcalfe RA, Crisp M, Ludgate M, Weetman AP 1998 The sodium iodide symporter gene and its regulation by cytokines found in autoimmunity. J Endocrinol 158:351-358
20. Thomas Jr CG, Croom 3rd RD 1987 Current management of the patient with autonomously functioning nodular goiter. Surg Clin North Am 67:315-328
21. Jhiang SM, Cho JY, Ryu KY, DeYoung BR, Smanik PA, McGaughy VR, Fischer AH, Mazzaferri EL 1998 An immunohistochemical study of Na+/I-symporter in human thyroid tissues and salivary gland tissues. Endocrinology 139:4416-4419
22. Lin JD, Chan EC, Chao TC, Chen KT, Hsueh C, Ho YS, Weng HF 2000 Expression of sodium iodide symporter in metastatic and follicular human thyroid tissues. Ann Oncol 11:625-629
23. Castro MR, Bergert ER, Beito TG, Roche PC, Ziesmer SC, Jhiang SM, Goellner JR, Morris JC 1999 Monoclonal antibodies against the human sodium iodide symporter: Utility for immunocytochemistry of thyroid cancer. J Endocrinol 163:495-504
24. Saito T, Endo T, Kawaguchi A, Ikeda M, Katoh R, Kawaoi A, Muramatsu A, Onaya T 1998 Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas. J Clin Invest 101:1296-1300
25. Wapnir IGR, Dohan O, Amenta P, Carrasco N 2001 NIS expression in thyroid cancer. Proc ASCO 20:336b
26. Lazar V, Bidart JM, Caillou B, Mahe C, Lacroix L, Filetti S, Schlumberger M 1999 Expression of the Na+/I- symporter gene in human thyroid tumors: A comparison study with other thyroid-specific genes. J Clin Endocrinol Metab 84:3228-3234
27. Feinmesser R, Lubin E, Segal K, Noyek A 1997 Carcinoma of the thyroid in children - A review. J Pediatr Endocrinol Metab 10:561-568
28. Zimmerman D 1997 Thyroid neoplasia in children [see comments]. Curr Opin Pediatr 9:413-418
29. Welch-Dinauer CA, Tuttle RM, Robie DK, McClellan DR, Svec RL, Adair C, Francis GL 1998 Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clin Endocrinol (Oxf) 49:619-6-28
30. McClellan DR, Francis GL 1996 Thyroid cancer in children, pregnant women, and patients with Graves' disease. Endocrinol Metab Clin North Am 25:27-48
31. Waldmann V, Rabes HM 1997 Absence of G(s)alpha gene mutations in childhood thyroid tumors after Chernobyl in contrast to sporadic adult thyroid neoplasia. Cancer Res 57:2358-2361
32. Fenton CL, Lukes Y, Nicholson D, Dinauer CA, Francis GL, Tuttle RM 2000 The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults. J Clin Endocrinol Metab 85:1170-1175
33. DeGroot LJ, Kaplan EL, McCormick M, Straus FH 1990 Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414-424
34. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS 1993 Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114:1050-1058
35. Hedinger C, Williams ED, Sobin LH 1989 The WHO histological classification of thyroid tumors: A commentary on the second edition. Cancer 63:908-911
36. Cho JY, Leveille R, Kao R, Rousset B, Parlow AF, Burak Jr WE, Mazzaferri EL, Jhiang SM 2000 Hormonal regulation of radioiodide uptake activity and Na+/I-symporter expression in mammary glands. J Clin Endocrinol Metab 85:2936-2943
37. Cho JY, Xing S, Liu X, Buckwalter TL, Hwa L, Sferra TJ, Chiu IM, Jhiang SM 2000 Expression and activity of human Na+/I-symporter in human glioma cells by adenovirus-mediated gene delivery. Gene Ther 7:740-749
38. Hung W 1992 Nodular thyroid disease and thyroid carcinoma. Pediatr Ann 21:50-57
39. Samaan NA, Schultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA, Ordonez NG 1992 The results of various modalities of treatment of well differentiated thyroid carcinomas: A retrospective review of 1599 patients. J Clin Endocrinol Metab 75:714-720
40. Wartofsky L 2000 An approach to the management of patients with scan negative, thyroglobulin positive, differentiated thyroid carcinoma. In: Wartofsky L (ed) Thyroid Cancer: A Comprehensive Guide to Clinical Management. Humana Press, Totowa, NJ, pp 251-261